Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Before you begin your journey with Chioma Okafor-Mbah, MD, dipl.ABOM, shell help you understand the importance of closely tracking your results and being patient
The medication is administered via subcutaneous injection, typically on a weekly basis, though dosing frequency and amounts may be individualized based on patient response and tolerability
In MCL (medial collateral ligament) transection studies, BPC-157 restored biomechanical properties to near-normal levels
You should speak with a provider before considering BPC-157 if you: Have a chronic medical condition Take prescription medications Have immune system concerns Have a history of cancer Are pregnant or breastfeeding Are recovering from surgery Have ongoing pain or unexplained inflammation Are using other peptides, hormones, or performance compounds BPC-157 should not replace proper diagnosis, imaging, rehab, or medical treatment for injuries
It is not a "drug" in the traditional sense, but shows strong regenerative properties in a range of physical injuries and inflammatory conditions
It is studied in the laboratory for the GHRH signalling pathway
